Device type · KXK
Source, Brachytherapy, Radionuclide
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KXK
Radiology
Device class
Class II
FDA decisions since 2015
18
510(k), De Novo and PMA
Adverse event reports
14
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Source, Brachytherapy, Radionuclide
- Product code
- KXK
- Device class
- Class II
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
- Specialty
- Radiology & Imaging
- FDA record
- Classification database entry for KXK
Latest FDA decisions
The 8 newest of 18 since 2015.
- OncoPatch510(k)
K252296 · Decided Dec 5, 2025 · 135 days after receipt
Device type: Source, Brachytherapy, Radionuclide (KXK) · Radiology & Imaging
- IsoSphere510(k)
K242818 · Decided Jul 15, 2025 · 300 days after receipt
Device type: Source, Brachytherapy, Radionuclide (KXK) · Radiology & Imaging
K223465 · Decided Jan 11, 2023 · 55 days after receipt
Device type: Source, Brachytherapy, Radionuclide (KXK) · Radiology & Imaging
15 more FDA decisions with a free account
Reports received
14
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
13
93% of reports
Injury reports
1
7.1% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 1 | 0 | 0 | 0 |
| Feb 24 | 1 | 0 | 0 | 0 |
| Mar 24 | 4 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 2 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 1 | 2 | 0 | 0 |
| Nov 24 | 1 | 0 | 0 | 0 |
| Dec 24 | 2 | 0 | 0 | 0 |
| Jan 25 | 1 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 1 | 0 | 0 |
| Sep 25 | 4 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 3 | 0 | 0 | 0 |
| Mar 26 | 4 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 1 | 0 | 0 | 0 |
| Jun 26 | 2 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 1 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Inaccurate Information10
- Unclear Information4
- Mechanical Jam2
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions14
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1702-2018 · Started Apr 10, 2018 · Posted by FDA Apr 27, 2018
Reason given: Bard Medical Division is recalling the BARD BrachySource Iodine125 Radioactive Seeds in Mick Applicators and BARD BrachySource Iodine125 Radioactive Seeds Loose in Vial with Sterile Spacers. Because the incorrect dosage level radioactive seeds were mixed up and sent to two hospitals. One Hospital ordered BrachySource...
Cause as FDA categorized it: Labeling mix-ups
Z-0267-2018 · Started Dec 9, 2016
Reason given: Activity and quantity of seeds sent in shipments were incorrect.
Cause as FDA categorized it: Other
Z-1385-2012 · Started Jan 25, 2012 · Posted by FDA Apr 10, 2012
Reason given: Brachytherapy device requires the user to enter radioactive source activity, but software may specify unintended units for activity and lead to overdose in patient treatment.
Cause as FDA categorized it: Labeling design
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.